| BoNT(s) | Botulinum Neurotoxin(s) |
| SP | Substance P |
| CGRP | Calcitonin Gene-Related Peptide |
| TRPA1 | Transient Receptor Potential Ankyrin 1 |
| TRPV1 | Transient Receptor Potential Vanilloid 1 |
| P2X3 | P2X Purinoceptor 3 |
| FDA | Food and Drug Administration |
| OAB | Overactive Bladder |
| UTI | Urinary Tract Infections |
| TN | Trigeminal Neuralgia |
| HIT-6 | Headache Impact Test |
| SNARE | Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor |
| SNAP-25 | Synaptosomal-Associated Protein of 25 kDa |
| IL1β | Interleukin-1β |
| VAMP | Vesicle-Associated Membrane Protein |
| IL6 | Interleukin 6 |
| BiTox | Binary Toxin |
| BiTox/AA | Binary Toxin-AA |
| TetBot | Tetanus-Botulinum Chimera |
| CFA | Freund’s Complete Adjuvant |
| SP-Bot | Substance P-Bot |
| Derm-Bot | Dermorphin-Bot |
| el-iBoNT | Elongated Isopeptide-Bonded Botulinum Neurotoxin |